Analyze Diet
American journal of veterinary research1975; 36(4 Pt.1); 445-448;

Immunity and the level of neutralization antibodies in foals and mares vaccinated with a modified live-virus rhinopneumonitis vaccine.

Abstract: Foals (farms 1 and 2) and mares (farms 1 and 3) vaccinated with a commercially available rhinopneumonitis vaccine were tested for the level of antibodies and for protection against the natural infection. The serum-neutralization (SN) antibody titers against equine herpesvirus type 1 were 1:8 or less in the majority of foals and 1:16 or higher in about 10%. The level of the nasal secretory antibody in the foals (farm 2) was less than 1:4. The vaccinated foals did not show any apparent respiratory tract infection for about 6 months and then an epizootic of respiratory tract disease appeared on farm 1 involving 3 foals. From each of these 3 foals herpesvirus was isolated. On farm 1, about 50% of the vaccinated mares aborted, and on farm 3, there were no abortions. Isolations of herpesvirus were made from 5 of the 6 aborted fetuses (farm 1). The SN antibody titers of the pregnant mares in the 2 farms at the time of foaling were high.
Publication Date: 1975-04-01 PubMed ID: 164808
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research conducted evaluates the effectiveness of a rhinopneumonitis vaccine in foals and mares, identifying the antibody levels and assessing protection against natural infections. The study finds notable variations in antibody levels, along with differences in infection and abortion rates amongst the test subjects.

Subject and Methodology

  • This study primarily focused on foals and mares that were vaccinated with a commercially available rhinopneumonitis vaccine.
  • These subjects were divided into separate groups housed at different farms and were assessed individually based on a number of factors.
  • The research experiment aimed to measure the level of antibodies and gauge the protection against natural infections that the vaccine offered.

Key Findings

  • The serum-neutralization (SN) antibody titers against equine herpesvirus type 1 were 1:8 or less in the majority of foals, signifying a low level of antibodies produced. On the other hand, around 10% of foals showed a higher antibody titer of 1:16 or more.
  • The level of nasal secretory antibody in the foals was also recorded to be less than 1:4, showing relatively low amounts of these antibodies as well.
  • Among the vaccinated foals, respiratory tract infection remained absent for approximately six months. After this period, a spread of the disease was observed in farm 1, affecting three foals.
  • The disease was associated with the isolation of the herpes virus from each of these affected foals.

Effects on Pregnant Mares

  • The effects of the vaccine were also studied in pregnant mares. On farm 1, about 50% of vaccinated mares ended up aborting their fetuses.
  • The aborted fetuses, 5 of the 6, had isolations of the herpes virus, indicating a connection between the disease and the abortions.
  • On the other hand, farm 3, where vaccinated mares were also kept, reported no instances of abortion.
  • Interestingly, the SN antibody levels of the pregnant mares in both the farms at the time of foaling were high, suggesting the potential for better immunity after childbirth.

Cite This Article

APA
Dutta SK, Shipley WD. (1975). Immunity and the level of neutralization antibodies in foals and mares vaccinated with a modified live-virus rhinopneumonitis vaccine. Am J Vet Res, 36(4 Pt.1), 445-448.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 36
Issue: 4 Pt.1
Pages: 445-448

Researcher Affiliations

Dutta, S K
    Shipley, W D

      MeSH Terms

      • Abortion, Veterinary / microbiology
      • Abortion, Veterinary / prevention & control
      • Animals
      • Antibodies, Viral
      • Female
      • Herpesviridae / immunology
      • Herpesviridae / isolation & purification
      • Herpesviridae Infections / microbiology
      • Herpesviridae Infections / prevention & control
      • Herpesviridae Infections / veterinary
      • Horse Diseases / microbiology
      • Horse Diseases / prevention & control
      • Horses / immunology
      • Immunity
      • Injections, Intramuscular
      • Neutralization Tests
      • Pregnancy
      • Respiratory Tract Infections / microbiology
      • Respiratory Tract Infections / prevention & control
      • Respiratory Tract Infections / veterinary
      • Vaccination / veterinary
      • Viral Vaccines / administration & dosage

      Citations

      This article has been cited 4 times.
      1. Blythe LL, Mattson DE, Lassen ED, Craig AM. Antibodies against equine herpesvirus 1 in the cerebrospinal fluid in the horse.. Can Vet J 1985 Jul;26(7):218-20.
        pubmed: 17422553
      2. Gibson JS, Slater JD, Awan AR, Field HJ. Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation.. Arch Virol 1992;123(3-4):351-66.
        doi: 10.1007/BF01317269pubmed: 1314051google scholar: lookup
      3. Thomson GW, McCready R, Sanford E, Gagnon A. Case report: An outbreak of herpesvirus myeloencephalitis in vaccinated horses.. Can Vet J 1979 Jan;20(1):22-5.
        pubmed: 216473
      4. Dutta SK, Campbell DL. Cell mediated immunity in equine herpesvirus type 1 infection I. In vitro lymphocyte blastogenesis and serum neutralization antibody in normal parturient and aborting mares.. Can J Comp Med 1977 Oct;41(4):404-8.
        pubmed: 200317